Which malaria prophylaxis options are commonly used in deployed settings?

• A. Doxycycline, chloroquine, and primaquine
• B. Mefloquine, chloroquine, and doxycycline
• C. Doxycycline, proguanil, and artesunate
• D. Doxycycline, atovaquone-proguanil, and mefloquine; choice depends on age, pregnancy, contraindications, and local resistance.

Answer: (D)

The main idea is balancing effectiveness against local parasite resistance with safety and practical considerations for the individual in a deployed setting. Doxycycline, atovaquone-proguanil, and mefloquine are the commonly used options, chosen based on who you are and where you are.

Doxycycline provides reliable protection with daily dosing and is typically affordable and easy to stock, but it cannot be used in pregnancy or in very young children, and sun exposure can be a concern. Atovaquone-proguanil is highly effective and well tolerated, with the advantage of simple daily dosing, but it’s more expensive and is generally avoided in the first trimester of pregnancy and in certain medical conditions; dosing is weight-based and adherence matters. Mefloquine is taken weekly, which can aid adherence and is useful in areas with resistance to other drugs, but it carries a risk of neuropsychiatric side effects and has specific contraindications, including certain psychiatric conditions.

Chloroquine-containing regimens and certain monotherapies are less favored in many deployed regions due to widespread resistance, making the trio above the more practical choices. The best option is selected by weighing age, pregnancy status, contraindications, and local resistance patterns to ensure effective protection for that individual in that setting.